{
    "clinical_study": {
        "@rank": "141269", 
        "arm_group": [
            {
                "arm_group_label": "vitamin D deficient,", 
                "description": "Vitamin D deficiency (serum level <20ng/ml)"
            }, 
            {
                "arm_group_label": "Vitamin D normal", 
                "description": "Serum level >35 ng/ml"
            }
        ], 
        "biospec_descr": {
            "textblock": "We will focus on proliferation and cytokine production to myelin basic protein (MBP) and\n      myelin oligodendrocyte glycoprotein (MOG) peptides and on the percentage of Th1 (IFN gamma\n      producing cells) and Th17 (IL-17 producing cells) during in vitro polarization assays"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Assessing the immune activation in MS patients deficient in Vitamin D and whether Vitamin D\n      supplementation reverse the immune activation\n\n      Evaluating whether Vitamin D deficiency result in lower cognitive performance in MS patients\n      and the effect of Vitamin D supplementation on reversing the cognitive impairment?"
        }, 
        "brief_title": "Effect of Vitamin D Replacement on Immune Function and Cognition in MS Patients", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Multiple Sclerosis (MS)", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "We will compare the immune responses in patients with Vitamin D deficiency (serum level\n      <20ng/ml) to those of patients with normal Vitamin D (serum level >35 ng/ml). We will focus\n      on proliferation and cytokine production to myelin basic protein (MBP) and myelin\n      oligodendrocyte glycoprotein (MOG) peptides and on the percentage of Th1 (IFN gamma\n      producing cells) and Th17 (IL-17 producing cells) during in vitro polarization assays. Our\n      hypothesis is that patients with low Vitamin D have increase proliferation to MBP and MOG\n      and increased production of pro-inflammatory cytokines (IFN gamma and IL-17) and that\n      Vitamin D supplementation will decrease this pro-inflammatory profile.\n\n      We will measure cognitive performance in patients with Vitamin D deficiency (serum level\n      <20ng/ml) compared to those of patients with normal Vitamin D (serum level >35 ng/ml) after\n      adjusting for educational levels and disease duration. We hypothesize that low Vitamin D has\n      a negative effect on cognitive performance and that Vitamin D supplementation will improve\n      cognitive function."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Definite diagnosis of Multiple Sclerosis following the revised McDonald MS diagnostic\n             criteria\n\n          2. Male and Female Aged 18 and above\n\n          3. On interferon-\u03b2 treatment (Rebif\u00ae, Avonex\u00ae, or Betaseron\u00ae)\n\n          4. No signs of active inflammation or attack or new lesions on MRI\n\n        Exclusion Criteria:\n\n          1. Treatment with immune modulating/ suppressive drugs other than IFN-b within 6 weeks\n             prior to enrolment\n\n          2. Pregnancy\n\n          3. Hypercalcemia\n\n          4. eglomerular filtration rate<60\n\n          5. History of primary hyperparathyroidism, hypercalcemia, renal dysfunction, cardiac\n             disease, malignancy, or granulomatous disease\n\n          6. The occurrence of an exacerbation (defined as an episode of neurologic dysfunction\n             lasting at least 24 hours) within 4 weeks of enrollment\n\n          7. History of dementia or related disorders\n\n          8. History of traumatic brain injury\n\n          9. Diagnosis of epilepsy or history of seizure\n\n         10. Diagnosis of psychiatric disease, substance abuse/dependence, alcohol\n             abuse/dependence\n\n         11. Currently, on any of the following medications Lithium, or Thiazide diuretics"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Group 1: low vitamin D (less than 25  ng/ml) Group 2: normal vitamin D level (greater than\n        35 ng/ ml)"
            }
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01952483", 
            "org_study_id": "IM.SK1.04"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Multiple Sclerosis (MS)", 
        "lastchanged_date": "September 25, 2013", 
        "location": {
            "contact": {
                "email": "ee04@aub.edu.lb", 
                "last_name": "elie m el hajj, masters", 
                "phone": "01374374", 
                "phone_ext": "7436"
            }, 
            "contact_backup": {
                "email": "vn01@aub.edu.lb", 
                "last_name": "vicky M nassar, Masters", 
                "phone": "01374374", 
                "phone_ext": "7420"
            }, 
            "facility": {
                "address": {
                    "city": "Beirut", 
                    "country": "Lebanon", 
                    "state": "Riad El Solh", 
                    "zip": "11-0236"
                }, 
                "name": "AUBMC Multiple Sclerosis Center"
            }, 
            "investigator": {
                "last_name": "samia j khoury, professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Lebanon"
        }, 
        "number_of_groups": "2", 
        "official_title": "Effect of Vitamin D Replacement on Immune Function and Cognition in MS Patients", 
        "overall_contact": {
            "email": "ee04@aub.edu.lb", 
            "last_name": "elie M Elhajj, masters", 
            "phone": "01374374", 
            "phone_ext": "7436"
        }, 
        "overall_contact_backup": {
            "email": "ri27@aub.edu.lb", 
            "last_name": "raed Ismail, MD", 
            "phone": "01374374", 
            "phone_ext": "7437"
        }, 
        "overall_official": {
            "affiliation": "AUBMC", 
            "last_name": "Samia J khoury, professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Lebanon: Ministry of Public Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "We will compare the immune responses in patients with Vitamin D deficiency (serum level <20ng/ml) to those of patients with normal Vitamin D (serum level >35 \u00b5g/ml). We will focus on proliferation and cytokine production to myelin basic protein (MBP) and myelin oligodendrocyte glycoprotein (MOG) peptides and on the percentage of Th1 (IFN gamma producing cells) and Th17 (IL-17 producing cells) during in vitro polarization assays. Our hypothesis is that patients with low Vitamin D have increase proliferation to MBP and MOG and increased production of pro-inflammatory cytokines (IFN gamma and IL-17) and that Vitamin D supplementation will decrease this pro-inflammatory profile.", 
            "measure": "Is there evidence of immune activation in MS patients deficient in Vitamin D and does Vitamin D supplementation reverse the immune activation?", 
            "safety_issue": "No", 
            "time_frame": "3months"
        }, 
        "reference": [
            {
                "PMID": "11385012", 
                "citation": "Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):773-80."
            }, 
            {
                "PMID": "15225816", 
                "citation": "Adorini L, Penna G, Giarratana N, Roncari A, Amuchastegui S, Daniel KC, Uskokovic M. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):437-41. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01952483"
        }, 
        "responsible_party": {
            "investigator_affiliation": "American University of Beirut Medical Center", 
            "investigator_full_name": "Samia Khoury", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "We will measure cognitive performance in patients with Vitamin D deficiency (serum level <20ng/ml) compared to those of patients with normal Vitamin D (serum level >35 ng/ml) after adjusting for educational levels and disease duration. We hypothesize that low Vitamin D has a negative effect on cognitive performance and that Vitamin D supplementation will improve cognitive function.", 
            "measure": "Does Vitamin D deficiency result in lower cognitive performance in MS patients and does Vitamin D supplementation reverse the cognitive impairment?", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "source": "American University of Beirut Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "American University of Beirut Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "3 Months", 
        "verification_date": "September 2013"
    }
}